European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments
- PMID: 35286560
- DOI: 10.1007/s12094-022-02807-w
European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments
Abstract
Purpose: To assess the methodological quality of all relevant and recent European clinical practice guidelines (CPGs) for advanced oesophageal and gastric cancers, and to synthesise their recommendations on the use of chemotherapy.
Methods: We searched PubMed, EMBASE, guidelines repositories, and other sources from 2010 onwards. We appraised quality using AGREE-II and AGREE-REX.
Results: 11 CPGs were included (five high, five low, and one moderate quality). Most guidelines showed deficiencies in the domain "applicability", with only three scoring above 60%. Nine did not report having sought the views and preferences of the target population. The lowest scores for AGREE-REX were item Values and Preferences of Target Users (1.6; SD 1.3), and item Values and Preferences of Policy/Decision-Makers (1.8; SD 1.7). The domain Clinical Applicability got the highest score and the domain Implementability got the lowest.
Conclusions: An urgent area of research is how to develop credible and implementable recommendations on the clinical use of CT for advanced oesophageal and gastric cancer.
Systematic review registration: PROSPERO (CRD42021236753).
Keywords: Chemotherapy; Esophageal neoplasms; Practice guidelines as topic; Review; Stomach neoplasms.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).
References
-
- Bettio M, Carvalho RN, Dimitrova N, Dyba T. Measuring the cancer burden in Europe: The European Cancer Information System (ECIS). Ann Oncol. 2019;30:v675. - DOI
-
- Hofmarcher T, Lindgren P. The cost of cancers of the digestive system in Europe. https://digestivecancers.eu/wp-content/uploads/2020/10/IHE_DiCE_HealthEc... . Accessed 9 Aug 2021.
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
-
- Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19:5598–606. - DOI
-
- Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354–62. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
